On August 13, Lumentum declined 3.22% in regular trading, trading at $902.16/share, with turnover of $2.971 billion. The pullback came one session after the stock surged over 14% on a comprehensive Q4 earnings beat and above-consensus Q1 guidance.

On the news front, Bank of America lowered its target price on Lumentum from $1,100 to $1,000 while maintaining a Neutral rating, triggering profit-taking pressure. Additionally, Morgan Stanley noted that investor enthusiasm will remain tempered until there is clearer visibility on near-packaged optics (NPO), which is considered the next major catalyst. The company did not provide NPO-related details this quarter, with formal announcements expected in subsequent quarters. Morgan Stanley raised its target to $1,000 from $900 but kept an Equal-weight rating, suggesting the stock needs concrete NPO contract disclosures to sustain further upside.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)